CIK: 0001622627 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $210,890 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYS INC | 3,300,389 | $33,004 | 15.6% | $6.89 | +102.4% | COM NEW | 24661P807 |
| FENC | FENNEC PHARMACEUTICALS INC | 2,045,644 | $16,979 | 8.1% | $5.68 | +20.5% | COM | 31447P100 |
| CYTK | CYTOKINETICS INC | 400,000 | $13,216 | 6.3% | $34.78 | 0.0% | COM NEW | 23282W605 |
| OCUL | OCULAR THERAPEUTIX INC | 1,218,700 | $11,310 | 5.4% | $7.23 | +8.2% | COM | 67576A100 |
| IDYA | IDEAYA BIOSCIENCES INC | 511,132 | $10,744 | 5.1% | $21.31 | -9.9% | COM | 45166A102 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 2,155,594 | $10,067 | 4.8% | $1.86 | +146.1% | COM | 98422E103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 700,000 | $9,786 | 4.6% | $16.51 | -17.8% | COM | 92790C104 |
| — | VERONA PHARMA PLC | 100,000 | $9,458 | 4.5% | $20.69 | — | SPONSORED ADS | 925050106 |
| VSTM | VERASTEM INC | 2,043,563 | $8,481 | 4.0% | $5.37 | +16.6% | COM NEW | 92337C203 |
| REPL | REPLIMUNE GROUP INC | 900,000 | $8,361 | 4.0% | $12.11 | -27.9% | COM | 76029N106 |
| MDWD | MEDIWOUND LTD | 407,061 | $7,885 | 3.7% | $11.00 | +71.3% | SHS NEW | M68830112 |
| MYO | MYOMO INC | 3,595,788 | $7,767 | 3.7% | $3.20 | +13.3% | COM NEW | 62857J201 |
| RZLT | REZOLUTE INC | 1,741,211 | $7,766 | 3.7% | $3.71 | 0.0% | COM NEW | 76200L309 |
| URGN | UROGEN PHARMA LTD | 542,366 | $7,430 | 3.5% | $11.86 | -19.1% | COM | M96088105 |
| HELP | CYBIN INC | 810,918 | $6,804 | 3.2% | $10.16 | -28.4% | COM NEW | 23256X407 |
| SVRA | SAVARA INC | 2,654,944 | $6,053 | 2.9% | $3.49 | -22.0% | COM | 805111101 |
| NSPR | INSPIREMD INC | 2,289,099 | $5,196 | 2.5% | $2.49 | +0.1% | COM | 45779A846 |
| CGON | CG ONCOLOGY INC | 192,974 | $5,017 | 2.4% | $24.10 | 0.0% | COM | 156944100 |
| PROF | PROFOUND MED CORP | 692,185 | $4,084 | 1.9% | $8.96 | -41.0% | COM NEW | 74319B502 |
| PHVS | PHARVARIS N V | 223,627 | $3,936 | 1.9% | $16.87 | -4.5% | COM | N69605108 |
| PYPD | POLYPID LTD | 975,462 | $3,443 | 1.6% | $4.49 | -34.7% | COM | M8001Q126 |
| — | MIND MEDICINE MINDMED INC | 420,000 | $2,726 | 1.3% | $5.85 | — | COM NEW | 60255C885 |
| KALV | KALVISTA PHARMACEUTICALS INC | 157,725 | $1,783 | 0.8% | $9.48 | +29.0% | COM | 483497103 |
| — | INMUNE BIO INC | 1,033,200 | $1,764 | 0.8% | — | — | Put | 45782T955 |
| TRVI | TREVI THERAPEUTICS INC | 300,000 | $1,641 | 0.8% | $2.31 | +169.5% | COM | 89532M101 |
| CMPS | COMPASS PATHWAYS PLC | 482,651 | $1,351 | 0.6% | $7.79 | — | SPONSORED ADS | 20451W101 |
| TLPH | TALPHERA INC | 2,003,939 | $922 | 0.4% | $0.62 | -19.3% | COM NEW | 00444T209 |
| BFRI | BIOFRONTERA INC | 976,448 | $695 | 0.3% | $1.04 | -32.7% | COM NEW | 09077D209 |
| — | UROGEN PHARMA LTD | 100,000 | $600 | 0.3% | — | — | Call | M96088905 |
| KURA | KURA ONCOLOGY INC | 100,000 | $577 | 0.3% | $7.79 | -21.4% | COM | 50127T109 |
| — | SPDR SERIES TRUST | 550,000 | $534 | 0.3% | — | — | Put | 78464A950 |
| — | REPLIMUNE GROUP INC | 231,800 | $516 | 0.2% | — | — | Call | 76029N906 |
| — | SPDR S&P 500 ETF TR | 250,000 | $433 | 0.2% | — | — | Put | 78462F953 |
| — | ATYR PHARMA INC | 223,000 | $271 | 0.1% | — | — | Put | 002120952 |
| OVID | OVID THERAPEUTICS INC | 500,000 | $165 | 0.1% | $0.30 | 0.0% | COM | 690469101 |
| — | IDEAYA BIOSCIENCES INC | 20,000 | $68 | 0.0% | — | — | Call | 45166A902 |
| — | CRINETICS PHARMACEUTICALS IN | 52,700 | $58 | 0.0% | — | — | Call | 22663K907 |